Gossamer Bio Inc (NASDAQ:GOSS) shares, rose in value, with the stock price up by 4.29% to the previous day’s close as strong demand from buyers drove the stock to $1.46.
Actively observing the price movement in the last trading, the stock closed the session at $1.40. Referring to stock’s 52-week performance, its high was $1.88, and the low was $0.45. On the whole, GOSS has fluctuated by 50.92% over the past month.
With the market capitalization of Gossamer Bio Inc currently standing at about $329.35 million, investors are eagerly awaiting this quarter’s results, scheduled for May 07, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.18, which is expected to increase to -$0.14 for fiscal year -$0.74 and then to about -$0.69 by fiscal year 2025. Data indicates that the EPS growth is expected to be 37.30% in 2025, while the next year’s EPS growth is forecast to be 6.80%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that GOSS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium term indicators have put the stock in the category of 100% Buy while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of GOSS currently trading nearly 10.40% and 37.65% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 65.25, while the 7-day volatility ratio is showing 8.06% which for the 30-day chart, stands at 11.49%. Furthermore, Gossamer Bio Inc (GOSS)’s beta value is 1.72, and its average true range (ATR) is 0.12.
A comparison of Gossamer Bio Inc (GOSS) with its peers suggests the former has fared considerably weaker in the market. GOSS showed an intraday change of 4.29% in last session, and over the past year, it grew by 10.61%%.
Data on historical trading for Gossamer Bio Inc (NASDAQ:GOSS) indicates that the trading volumes over the past 10 days have averaged 1.54 million and over the past 3 months, they’ve averaged 1.17 million. According to company’s latest data on outstanding shares, there are 225.41 million shares outstanding.
Nearly 16.30% of Gossamer Bio Inc’s shares belong to company insiders and institutional investors own 79.44% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 14.3 million shares as on Feb 29, 2024, resulting in a short ratio of 11.54. According to the data, the short interest in Gossamer Bio Inc (GOSS) stood at 6.34% of shares outstanding as of Feb 29, 2024; the number of short shares registered in Jan 31, 2024 reached 16.72 million. The stock has risen by 60.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GOSS stock heading into the next quarter.
